Pseudomonas aeruginosa Infection in Cystic Fibrosis: A Paradigm of Chronic Infection

Michelle Prickett*, Manu Jain

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Pseudomonas aeruginosa is a frequently encountered pathogen in multiple clinical settings. In acute infections, particularly in immunocompromised patients, the bacteria can increase expression of virulence factors such as type III secretion toxins with high mortality rates. In contrast, P. aeruginosa may cause chronic infections in patients with impaired local host defenses such as bronchiectasis. The best example of this is in patients with cystic fibrosis (CF) in which P. aeruginosa can reside for years to decades due to its ability to adapt in the CF lung. Changes by P. aeruginosa in patients with CF over time include the loss of virulence factors while also acquiring antibiotic resistance, making treatment difficult. This article reviews these adaptations in P. aeruginosa using the knowledge learned from study of patients with CF, which may also be applicable to other chronic lung diseases.

Original languageEnglish (US)
Pages (from-to)53-59
Number of pages7
JournalClinical Pulmonary Medicine
Volume18
Issue number2
DOIs
StatePublished - Mar 1 2011

Fingerprint

Pseudomonas Infections
Cystic Fibrosis
Pseudomonas aeruginosa
Infection
Virulence Factors
Bronchiectasis
Immunocompromised Host
Microbial Drug Resistance
Lung Diseases
Chronic Disease
Bacteria
Lung
Mortality

Keywords

  • Pseudomonas aeruginosa
  • chronic lung infections
  • cystic fibrosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

@article{d8f2bb25dbbe46d4a07081241dadc38d,
title = "Pseudomonas aeruginosa Infection in Cystic Fibrosis: A Paradigm of Chronic Infection",
abstract = "Pseudomonas aeruginosa is a frequently encountered pathogen in multiple clinical settings. In acute infections, particularly in immunocompromised patients, the bacteria can increase expression of virulence factors such as type III secretion toxins with high mortality rates. In contrast, P. aeruginosa may cause chronic infections in patients with impaired local host defenses such as bronchiectasis. The best example of this is in patients with cystic fibrosis (CF) in which P. aeruginosa can reside for years to decades due to its ability to adapt in the CF lung. Changes by P. aeruginosa in patients with CF over time include the loss of virulence factors while also acquiring antibiotic resistance, making treatment difficult. This article reviews these adaptations in P. aeruginosa using the knowledge learned from study of patients with CF, which may also be applicable to other chronic lung diseases.",
keywords = "Pseudomonas aeruginosa, chronic lung infections, cystic fibrosis",
author = "Michelle Prickett and Manu Jain",
year = "2011",
month = "3",
day = "1",
doi = "10.1097/CPM.0b013e31820e3506",
language = "English (US)",
volume = "18",
pages = "53--59",
journal = "Clinical Pulmonary Medicine",
issn = "1068-0640",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

Pseudomonas aeruginosa Infection in Cystic Fibrosis : A Paradigm of Chronic Infection. / Prickett, Michelle; Jain, Manu.

In: Clinical Pulmonary Medicine, Vol. 18, No. 2, 01.03.2011, p. 53-59.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pseudomonas aeruginosa Infection in Cystic Fibrosis

T2 - A Paradigm of Chronic Infection

AU - Prickett, Michelle

AU - Jain, Manu

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Pseudomonas aeruginosa is a frequently encountered pathogen in multiple clinical settings. In acute infections, particularly in immunocompromised patients, the bacteria can increase expression of virulence factors such as type III secretion toxins with high mortality rates. In contrast, P. aeruginosa may cause chronic infections in patients with impaired local host defenses such as bronchiectasis. The best example of this is in patients with cystic fibrosis (CF) in which P. aeruginosa can reside for years to decades due to its ability to adapt in the CF lung. Changes by P. aeruginosa in patients with CF over time include the loss of virulence factors while also acquiring antibiotic resistance, making treatment difficult. This article reviews these adaptations in P. aeruginosa using the knowledge learned from study of patients with CF, which may also be applicable to other chronic lung diseases.

AB - Pseudomonas aeruginosa is a frequently encountered pathogen in multiple clinical settings. In acute infections, particularly in immunocompromised patients, the bacteria can increase expression of virulence factors such as type III secretion toxins with high mortality rates. In contrast, P. aeruginosa may cause chronic infections in patients with impaired local host defenses such as bronchiectasis. The best example of this is in patients with cystic fibrosis (CF) in which P. aeruginosa can reside for years to decades due to its ability to adapt in the CF lung. Changes by P. aeruginosa in patients with CF over time include the loss of virulence factors while also acquiring antibiotic resistance, making treatment difficult. This article reviews these adaptations in P. aeruginosa using the knowledge learned from study of patients with CF, which may also be applicable to other chronic lung diseases.

KW - Pseudomonas aeruginosa

KW - chronic lung infections

KW - cystic fibrosis

UR - http://www.scopus.com/inward/record.url?scp=79953130712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953130712&partnerID=8YFLogxK

U2 - 10.1097/CPM.0b013e31820e3506

DO - 10.1097/CPM.0b013e31820e3506

M3 - Article

AN - SCOPUS:79953130712

VL - 18

SP - 53

EP - 59

JO - Clinical Pulmonary Medicine

JF - Clinical Pulmonary Medicine

SN - 1068-0640

IS - 2

ER -